Navigation Links
Intrinsic Therapeutics' Barricaid and Magellan Spine Technologies' DART to Drive European Annulus Repair Market
Date:6/29/2009

Two new products to allow for additional spine treatments performed during discectomy procedures, according to Millennium Research Group

WALTHAM, Mass., June 29 /PRNewswire/ -- According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, new annulus repair devices that have entered the European spinal implant market will be key factors contributing to market growth through 2013. MRG's European Markets for Spinal Implants 2009 report finds that the annulus repair segment will form a niche market within the European spinal implant market that will exceed $670 million by 2013.

In April 2009, the first annulus repair device became available in Europe when Intrinsic Therapeutics' Barricaid device received CE marking. Later that month, Magellan Spine Technologies' Disc Annular Repair Technology (DART) System was also granted approval. As these and other companies increasingly promote their products and train surgeons to use them, adoption of annulus repair devices will grow rapidly through 2013.

"Through 2013 and beyond, companies will continue their efforts to demonstrate the benefits of combining annulus repair devices with discectomies, namely fewer costly revisions," says Kevin Flewwelling, Manager of MRG's Orthopedics division. "This will not only boost surgeon confidence in the procedures, which at the moment is low because the devices are so new, but it will also encourage governments and regulatory bodies across Europe to grant reimbursement for annulus repair devices because it will reduce the number of expensive discectomy revisions."

The accumulation of clinical evidence and socioeconomic data that displays how governments can save money by reducing discectomy revisions will be supported by the entrance of new competitors, such as Anulex Technologies, the 2008 leader of the US annulus repair market. The growth of lead
'/>"/>

SOURCE Millennium Research Group
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Intrinsic Therapeutics Announces CE Mark for Barricaid Anular Prosthesis
2. Cell Therapeutics Completes Pixantrone NDA Submission and Requests Priority Review
3. Prospect Therapeutics Inc.s GCS-100 Has Focused on Developing Treatment for Three Blood-Borne Cancers
4. Cell Therapeutics Announces Final Results of its Fixed Price Exchange Offers for Any and All of its $118.9 Million Convertible Notes Outstanding
5. Transition Therapeutics Announces Appointment of Vice-President of Clinical Operations
6. Leaders from the Field of Pain Therapeutics to Discuss Latest Discoveries and Breakthroughs at Arrowhead's 3rd Annual Pain Therapeutics Summit
7. Echo Therapeutics and Handok Pharmaceuticals Sign South Korea License for Needle-free Symphony(TM) Transdermal Continuous Glucose Monitoring System
8. Cell Therapeutics Announces Preliminary Results of its Fixed Price Exchange Offers for Any and All of its $118.9 Million Convertible Notes Outstanding
9. Elusys Therapeutics and Lonza Enter Into Manufacturing Agreement
10. Prospect Therapeutics In Vitro Studies Demonstrate that GCS-100 Drug Binds to and Blocks the Effects of Galectin-3
11. Cornerstone Therapeutics Inc. Announces Record Date and Meeting Date for Special Meeting of Stockholders for Vote with Respect to Issuance and Sale of Stock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/25/2014)... December 26, 2014 The microscopy ... of 7.2% to reach $5,756.0 million by 2019. ... microscopy market. The electron microscopes product segment is ... forecast period. , Rising focus on nanotechnology, technological ... of the microscopy market. , Get Full Copy ...
(Date:12/25/2014)... 26, 2014 The click ... beauty, strength and durability. Today, the business announces ... is valid until Jan. 30, 2015. , Click ... traditional hardwood. BambooFlooringChina.com is a well-known brand in ... worldwide to find a reliable bamboo flooring supplier. ...
(Date:12/25/2014)... 2014 The report “TS-1 (Colorectal Cancer) ... the current treatment landscape, unmet needs, current pipeline and ... an anti-cancer drug which is typically used for treating ... used for treating gastric cancer and pancreatic cancer. TS-1 ... drug was first approved in 1999 in Japan for ...
(Date:12/25/2014)... (PRWEB) December 26, 2014 “Every three months ... market changes. A-line sweetheart evening dress will be one of ... sales manager of Yunx.co.uk says. Today, the company releases 26 ... discounts, up to 80% off. , “We are trying ... unique style with our latest designs. Along with affordable prices, ...
(Date:12/25/2014)... (PRWEB) December 26, 2014 Recently, Dylan ... dresses, has excitedly released its collection of discounted prom ... to Percy, a senior spokesman of the company, the ... of this promotion is to expand the UK market. ... in several different colors, lengths, and styles: A-line strapless, ...
Breaking Medicine News(10 mins):Health News:Microscopy Market Hit to $5,756.0 Million by 2019 - New Research Report by MarketsandMarkets 2Health News:Microscopy Market Hit to $5,756.0 Million by 2019 - New Research Report by MarketsandMarkets 3Health News:Microscopy Market Hit to $5,756.0 Million by 2019 - New Research Report by MarketsandMarkets 4Health News:BambooFlooringChina.com: click strand woven bamboo flooring promotion valid until Jan. 30, 2015. 2Health News:TS-1 Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 2Health News:TS-1 Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 3Health News:Dylan Queen: Cheap Prom Dresses for the UK Market 2
... Sky One,Medical, Inc. ("China Sky One Medical" or ... fully integrated pharmaceutical company producing over-the-counter,drugs in the ... it,successfully obtained the production approval from the State ... additional drugs: Sodium Cromoglicate,Eye Drops for the treatment ...
... Re Ltd., the reinsurance unit of White Mountains Insurance Group, Ltd. ... Financial Officer, will retire from full-time work at the end of ... advisor to White Mountains. , , ... the last 7 years Chuck has filled many roles within our ...
... PITTSBURGH, Dec. 16 MED3OOO, Inc., a national healthcare management, ... able to help the City of Newark, Ohio recover lost ... companies. , , After partnering ... of Newark Division Fire & EMS department is now able ...
... Dec. 16 CeloNova BioSciences, Inc., announced,today that ... U.S. Food and,Drug Administration (FDA) for Embozene(TM) Color-Advanced ... tumors (tumors with a,large number of blood vessels ... circulatory system). U.S. commercial sales of,Embozene(TM) Microspheres will ...
... Dec. 16 While all cosmetic surgery,can be performed ... feel or remember their surgery - a condition commonly ... (Photo: http://www.newscom.com/cgi-bin/prnh/20081216/LATU002 ) , ... iv sedation, pioneered by anesthesiologist Dr. Barry L.,Friedberg, is ...
... more efficiently, Fresho.com offers bulk job posting and announces new job ad ... ... NY (PRWEB) December 16, 2008 -- In order to help employers fill ... search engine Fresho.com now offers employers to submit their job openings ...
Cached Medicine News:Health News:China Sky One Medical, Inc. Obtains Production Rights for Two Additional Drugs 2Health News:China Sky One Medical, Inc. Obtains Production Rights for Two Additional Drugs 3Health News:White Mountains Re Announces Management Changes -- Chokel to Retire and Remain Risk Advisor at WTM 2Health News:White Mountains Re Announces Management Changes -- Chokel to Retire and Remain Risk Advisor at WTM 3Health News:White Mountains Re Announces Management Changes -- Chokel to Retire and Remain Risk Advisor at WTM 4Health News:City of Newark, Ohio Increases Safety Services with EMS Revenue Recovered by MED3OOO EMS Billing 2Health News:City of Newark, Ohio Increases Safety Services with EMS Revenue Recovered by MED3OOO EMS Billing 3Health News:CeloNova BioSciences Receives FDA Market Approval for Embozene(TM) Color-Advanced Microspheres Embolization Platform 2Health News:CeloNova BioSciences Receives FDA Market Approval for Embozene(TM) Color-Advanced Microspheres Embolization Platform 3Health News:CeloNova BioSciences Receives FDA Market Approval for Embozene(TM) Color-Advanced Microspheres Embolization Platform 4Health News:Cosmetic Surgery -'Goldilocks' Anesthesia Is Not Mickey Mouse 2Health News:Fresho.Com Offers Efficient Job Postings for Employers and Recruiters 2
(Date:12/24/2014)... Dec. 23, 2014  Lockton Dunning Benefits, the ... Companies, announced the addition of Vice President ... Lockton Dunning,s Pharmacy Consulting team, Excelsior Solutions. ... industry experience to the position.  Most recently, she ... at Diplomat Specialty Pharmacy, where she has held ...
(Date:12/24/2014)... RALEIGH, N.C. , Dec. 23, 2014 /PRNewswire/ ... (NASDAQ: ENDP ) (TSX: ENL), and BioDelivery ... today that they have submitted a New Drug Application ... Food and Drug Administration (FDA).  Buprenorphine HCl Buccal Film ... enough to require daily, around-the-clock, long-term opioid treatment and ...
(Date:12/22/2014)... Dec. 22, 2014 Apnea Sciences ( www.apneasciences.com ... in Aliso Viejo , California.  ... the tremendous growth and worldwide expansion, a new facility ... SnoreRx, the anti snore cure have exceeded our expectations ... "We are now in 23 countries and will be ...
Breaking Medicine Technology:Kim Foerster Joins Lockton Companies 2Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain 2Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain 3Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain 4Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain 5
... 2010 Segal McCambridge Singer & Mahoney, Ltd. and ... in favor of medical device manufacturer I-Flow Corporation.  A ... the District of Oregon returned defense verdicts on all ... three plaintiffs whose cases had been consolidated for trial. ...
... Inc. (Nasdaq: SGMO ) announced today that Edward ... the progress of Sangamo,s ZFP Therapeutic® development programs and an ... on Tuesday, November 16, 2010, at the Lazard Capital Markets ... York City. A live webcast of the presentation ...
Cached Medicine Technology:Sangamo BioSciences Announces Presentation at Lazard Capital Markets Healthcare Conference 2
... Performance ,MARS Technology is the next generation ... an addition to our current family of ... advantage of new technological breakthroughs in signal ... pulse signal resulting in superior performance during ...
The NPB-40 Handheld Pulse Oximeter is both compact and affordable. It is simple to operate, provides spot-check monitoring of SpO 2 and pulse rate, and is compact enough to fit in your pocket....
... The Nellcor N-20PA Handheld Pulse Oximeter is ... The durable construction of the N-20PA has ... temperatures and conditions it has even ... is conveniently portable for spot check measurements ...
... Nellcor's most popular handheld oximeter has been ... platform and is now compatible with the ... the MAX-FAST Forehead Sensor and SoftCare Nonadhesive ... Oximeter also incorporates Nellcor's latest advanced signal ...
Medicine Products: